TOwards imProved screening for breast, cervical and colorectal cancer In All of Europe

Dates: September 2015 – August 2020  eutopia_logo
Funder: European Commission
ECOHOST staff involved: Martin McKee, Keti Glonti

The EU-TOPIA study is carried out in partnership with: Erasmus University, Netherlands; Cancer Society of Finland; City of Health and Science University Hospital of Turin, Italy; The Institute of Oncology Ljubljana, Slovenia; Health Development Institute, Estonia; and Syreon Clinical Research, Hungary.


The EU-TOPIA team

The study will systematically evaluate and quantify the harms and benefits of current programmes for breast, cervical, and colorectal cancer in all European countries, and identify ways to improve health outcomes and equity. Using quality indicators, outcomes and cost-effectiveness of existing cancer screening programmes in 2015 will be estimated. Models of the natural history of the cancers will be constructed using country-specific data, and barriers to implementation identified. Road maps for change with capacity for self-evaluation of screening will be built using web-based tools. The project aims to reduce inequity, number of cancer deaths and over-diagnosed cases, and increase life years gained and improve cost-effectiveness by 2025.